XCOPRI
XCOPRI
Approved
DIN Number
02538776
Drug Class
Human
Market Date
May 23, 2025
Company
HC
Endo Operations Ltd.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02538776
AIG Number0264762001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX25 CENOBAMATE
Product Specifications
Dosage FormKit
,
Tablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification
ACTIVE INGREDIENTS (2)
CENOBAMATEActive
Strength: 12.5 MG
Monograph: CENOBAMATE
CENOBAMATEActive
Strength: 25 MG
Monograph: CENOBAMATE